AP approvals fall as medicinal cannabis sales plateau, Penington report finds by Adam Sheldon December 3, 2025December 4, 2025 Medicinal cannabis growth slowed sharply in the first half of 2025 as regulators stepped up scrutiny […]
Cannim gets stay of execution as potential buyer moves in by Steve Jones December 3, 2025December 4, 2025
Elixinol names new chair in pursuit of ‘sustainable and profitable business’ by Steve Jones December 2, 2025February 21, 2026
Chinese investor behind Y Cannabis poised to take full control of Tasmanian Botanics in A$31m deal by Adam Sheldon December 2, 2025December 4, 2025
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
InhaleRx locks in A$1m cap raise and reveals plans to rebrand by Adam Sheldon December 1, 2025February 21, 2026
Biortica formally ends RTO bid and targets ASX listing in early 2026 by Steve Jones November 27, 2025December 4, 2025
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
Medicinal cannabis works. What’s broken is the culture around it by Dr Afraz Adams November 27, 2025November 27, 2025
